Endoscopic Ultrasound Evaluation of the Common Bile Duct in Patients With Obstructive Jaundice Due to Bilio-pancreatic Malignancies (ECCO Trial)
Completed
- Conditions
- Obstructive JaundiceBilio-pancreatic Tumor
- Registration Number
- NCT05155475
- Lead Sponsor
- Ramsay Générale de Santé
- Brief Summary
To assess the size of the common bile duct in a large cohort of patients with jaundice following a malignant tumor of the head of the pancreas or the distal bile duct receiving a diagnostic EA for biopsy and / or for evaluation of tissue resectability.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
- Patients with jaundice and an injury to the head of the pancreas recommended for EUS-guided tissue acquisition or staging
- Patients with jaundice and distal CBD lesion suggestive of cholangiocarcinoma or Vater's ampulla carcinoma recommended for EUS-guided tissue acquisition or staging
- Serum bilirubin level ≥ 3 mg / dl
- Age ≥ 18 years old
- Subject affiliated or beneficiary of a social security scheme.
- Subject having been informed of this study and having given his no objection
Exclusion Criteria
- Presence of altered anatomy due to previous gastric surgery (Billroth II or Roux-en-Y anastomosis)
- Sphincterotomy performed previously, plastic biliary stent or metal stent placement
- Percutaneous drainage of the bile ducts performed previously
- Pregnant, breastfeeding or parturient woman
- Protected patients: Adults under guardianship, curatorship or other legal protection, deprived of their liberty by judicial or administrative decision; hospitalized without consent.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the common bile duct size 1 day
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital Jean Mermoz
🇫🇷Lyon, France
Hôpital Jean Mermoz🇫🇷Lyon, France